跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Remifemin
Approved
STANDARD
Remifemin
Schaper & Brümmer GmbH & Co. KG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a9df2bf85a7e177b
Company
Schaper & Brümmer GmbH & Co. KG
Type
Standard
Approval Details
Approval Id
a9df2bf85a7e177b
Drug Approval Philippines Name
Remifemin
Product Name
Remifemin
Registration Number
DR-XY48447
Brand Name
Remifemin
Generic Name
Cimicifuga racemosa L. (Black Cohosh) Rhizome
Dosage Form
Tablet
Dosage Strength
2.5mg
Manufacturer
Schaper & Brümmer GmbH & Co. KG
Importer
BSV Bioscience Phils. Inc.
Distributor
BSV Bioessence Phils., Inc.
Company Detail Path
/organization/schaper-and-brummer-gmbh-and-co-kg
Issuance Date
28 October 2022
Expiry Date
28 October 2027
Pharmacologic Category
Non-Hormonal Gynecologic Phytomedicine
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a9df2bf85a7e177b
Type
Standard
Back to Philippines FDA Approvals
Remifemin - Philippines FDA Drug Approval Details